SpringerLink
Log in

Management of Portal Hypertension in the Older Patient

  • Published:
Current Gastroenterology Reports Aims and scope Submit manuscript

Abstract

Purpose of this review

Aging is a process of physiological slowing, reduced regenerative capacity and inability to maintain cellular homeostasis. World Health Organisation declared the commencement of population aging globally, largely attributed to improvement in the healthcare system with early diagnosis and effective clinical management. Liver ages similar to other organs, with reduction in size and blood flow. In this review we aim to evaluate the effect of aging in liver disease.

Recent findings

Aging causes dysregulation of major carbohydrate, fat and protein metabolism in the liver. Age is a major risk factor for liver fibrosis accelerated by sinusoidal endothelial dysfunction and immunological disharmony.

Age plays a major role in patients with liver cirrhosis and influence outcomes in patients with portal hypertension. Transient elastography may be an useful tool in the assessment of portal hypertension. Hepatic structural distortion, increased vascular resistance, state of chronic inflammation, associated comorbidities, lack of physiological reserve in the older population may aggravate portal hypertension in patients with liver cirrhosis and may result in pronounced variceal bleed. Cut-offs for other non-invasive markers of fibrosis may differ in the elderly population. Non-selective beta blockers initiated at lower dose followed by escalation are the first line of therapy in elderly patients with cirrhosis and portal hypertension, unless contraindicated. Acute variceal bleed in the elderly cirrhotic patients can be life threatening and may cause rapid exsanguination due to poor reserve and associated comorbidities. Vasoactive drugs may be associated with more adverse reactions. Early endoscopy may be warranted in the elderly patients with acute variceal bleed. Role of TIPS in the elderly cirrhotics discussed.

Summary

Management of portal hypertension in the older population may pose significant challenges to the treating clinician.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price includes VAT (Germany)

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. World Health Organisation. https://www.who.int/health-topics/Aging#tab=tab_1.

  2. Aalami OO, Fang TD, Song HM, Nacamuli RP. Physiological features of aging persons. Arch Surg. 2003;138(10):1068–76. https://doi.org/10.1001/archsurg.138.10.1068.

    Article  PubMed  Google Scholar 

  3. Chung HY, Cesari M, Anton S, Marzetti E, Giovannini S, Seo AY, Carter C, Yu BP, Leeuwenburgh C. Molecular inflammation: underpinnings of aging and age-related diseases. Aging Res Rev. 2009;8(1):18–30. https://doi.org/10.1016/j.arr.2008.07.002.

    Article  CAS  Google Scholar 

  4. Jackson RA, Blix PM, Matthews JA, Hamling JB, Din BM, Brown DC, Belin J, Rubenstein AH, Nabarro JD. Influence of Aging on glucose homeostasis. J Clin Endocrinol Metab. 1982;55(5):840–8. https://doi.org/10.1210/jcem-55-5-840.

    Article  CAS  PubMed  Google Scholar 

  5. Ward W, Richardson A. Effect of age on liver protein synthesis and degradation. Hepatology. 1991;14(5):935–48. https://doi.org/10.1002/hep.1840140529.

    Article  CAS  PubMed  Google Scholar 

  6. Kuhla A, Blei T, Jaster R, Vollmar B. Aging is associated with a shift of fatty metabolism toward lipogenesis. J Gerontol A Biol Sci Med Sci. 2011;66(11):1192–200. https://doi.org/10.1093/gerona/glr124.

    Article  CAS  PubMed  Google Scholar 

  7. Wynne HA, Cope LH, Mutch E, Rawlins MD, Woodhouse KW, James OF. The effect of age upon liver volume and apparent liver blood flow in healthy man. Hepatology. 1989;9(2):297–301. https://doi.org/10.1002/hep.1840090222.

    Article  CAS  PubMed  Google Scholar 

  8. Le Couteur DG, Cogger VC, Markus AM, Harvey PJ, Yin ZL, Ansselin AD, McLean AJ. Pseudocapillarization and associated energy limitation in the aged rat liver. Hepatology. 2001;33(3):537–43. https://doi.org/10.1053/jhep.2001.22754.

    Article  PubMed  Google Scholar 

  9. Fulop T, Larbi A, Kotb R, de Angelis F, Pawelec G. Aging, immunity, and cancer. Discov Med. 2011;11(61):537–50.

    PubMed  Google Scholar 

  10. • Kim IH, Kisseleva T, Brenner DA. Aging and liver disease. Curr Opin Gastroenterol. 2015;31(3):184–91. https://doi.org/10.1097/MOG.0000000000000176. Aging liver may respond differently to the insult which may result in higher morbidity and mortality.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Jothimani D, Danielraj S, Narasimhan G, Kaliamoorthy I, Rajakumar A, Palaniappan K, Palanichamy S, Rammohan A, Ramachandran H, Rajalingam R, Rela M. Nonalcoholic steatohepatitis: a rapidly increasing indication for liver transplantation in India. J Clin Exp Hepatol. 2022;12(3):908–16. https://doi.org/10.1016/j.jceh.2021.09.017.

    Article  CAS  PubMed  Google Scholar 

  12. Conti F, Buonfiglioli F, Scuteri A, Crespi C, Bolondi L, Caraceni P, Foschi FG, Lenzi M, Mazzella G, Verucchi G, Andreone P, Brillanti S. Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals. J Hepatol. 2016;65(4):727–33. https://doi.org/10.1016/j.jhep.2016.06.015.

    Article  CAS  PubMed  Google Scholar 

  13. Frith J, Jones D, Newton JL. Chronic liver disease in an Aging population. Age Aging. 2009;38(1):11–8. https://doi.org/10.1093/Aging/afn242.

    Article  Google Scholar 

  14. Frith J, Day CP, Henderson E, Burt AD, Newton JL. Non-alcoholic fatty liver disease in older people. Gerontology. 2009;55(6):607–13. https://doi.org/10.1159/000235677.

    Article  CAS  PubMed  Google Scholar 

  15. Goel A, Madhu K, Zachariah U, Sajith KG, Ramachandran J, Ramakrishna B, Gibikote S, Jude J, Chandy GM, Elias E, Eapen CE. A study of aetiology of portal hypertension in adults (including the elderly) at a tertiary centre in southern India. Indian J Med Res. 2013;137(5):922–7.

    PubMed  PubMed Central  Google Scholar 

  16. Floreani A. Liver diseases in the elderly: an update. Dig Dis. 2007;25(2):138–43. https://doi.org/10.1159/000099478.

    Article  PubMed  Google Scholar 

  17. • Moreau R, Gao B, Papp M, Bañares R, Kamath PS. Acute-on-chronic liver failure: A distinct clinical syndrome. J Hepatol. 2021;75(Suppl 1):S27–35. https://doi.org/10.1016/j.jhep.2020.11.047. ACLF is an important disease entity.

    Article  PubMed  Google Scholar 

  18. • Arroyo V, Moreau R, Jalan R, Ginès P, EASL-CLIF Consortium CANONIC Study. Acute-on-chronic liver failure: A new syndrome that will re-classify cirrhosis. J Hepatol. 2015;62(1 Suppl):S131-43. https://doi.org/10.1016/j.jhep.2014.11.045. Age is associated with increased mortality in ACLF.

    Article  PubMed  Google Scholar 

  19. Teh SH, Nagorney DM, Stevens SR, Offord KP, Therneau TM, Plevak DJ, Talwalkar JA, Kim WR, Kamath PS. Risk factors for mortality after surgery in patients with cirrhosis. Gastroenterology. 2007;132(4):1261–9. https://doi.org/10.1053/j.gastro.2007.01.040.

    Article  PubMed  Google Scholar 

  20. Harraz OF, Jensen LJ. Aging, calcium channel signaling and vascular tone. Mech Aging Dev. 2020;191:111336. https://doi.org/10.1016/j.mad.2020.111336.

    Article  CAS  PubMed  Google Scholar 

  21. Tsuchida T, Friedman SL. Mechanisms of hepatic stellate cell activation. Nat Rev Gastroenterol Hepatol. 2017;14(7):397–411. https://doi.org/10.1038/nrgastro.2017.38.

    Article  CAS  PubMed  Google Scholar 

  22. Wanless IR, Wong F, Blendis LM, Greig P, Heathcote EJ, Levy G. Hepatic and portal vein thrombosis in cirrhosis: possible role in development of parenchymal extinction and portal hypertension. Hepatology. 1995;21(5):1238–47.

    CAS  PubMed  Google Scholar 

  23. Chung HY, Kim DH, Lee EK, Chung KW, Chung S, Lee B, Seo AY, Chung JH, Jung YS, Im E, Lee J, Kim ND, Choi YJ, Im DS, Yu BP. Redefining chronic inflammation in aging and age-related diseases: proposal of the senoinflammation concept. Aging Dis. 2019;10(2):367–82. https://doi.org/10.14336/AD.2018.0324.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006;444(7121):860–7. https://doi.org/10.1038/nature05485.

    Article  CAS  PubMed  Google Scholar 

  25. •• Maeso-Díaz R, Ortega-Ribera M, Lafoz E, Lozano JJ, Baiges A, Francés R, Albillos A, Peralta C, García-Pagán JC, Bosch J, Cogger VC, Gracia-Sancho J. Aging influences hepatic microvascular biology and liver fibrosis in advanced chronic liver disease. Aging Dis. 2019;10(4):684–98. https://doi.org/10.14336/AD.2019.0127. Important to understand that gene expression varies in older cirrhotics, differing pathogenesis.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Ripoll C, Groszmann R, Garcia-Tsao G, Grace N, Burroughs A, Planas R, Escorsell A, Garcia-Pagan JC, Makuch R, Patch D, Matloff DS, Bosch J, Portal Hypertension Collaborative Group. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis. Gastroenterology. 2007;133(2):481–8. https://doi.org/10.1053/j.gastro.2007.05.024.

    Article  CAS  PubMed  Google Scholar 

  27. • Reiberger T. The value of liver and spleen stiffness for evaluation of portal hypertension in compensated cirrhosis. Hepatol Commun. 2022;6(5):950–64. https://doi.org/10.1002/hep4.1855. Non-invasive markers have an increasing role to play.

    Article  PubMed  Google Scholar 

  28. •• Tripathi D, Stanley AJ, Hayes PC, Patch D, Millson C, Mehrzad H, Austin A, Ferguson JW, Olliff SP, Hudson M, Christie JM, Clinical Services and Standards Committee of the British Society of Gastroenterology. U.K. guidelines on the management of variceal haemorrhage in cirrhotic patients. Gut. 2015;64(11):1680–704. https://doi.org/10.1136/gutjnl-2015-309262. Protocol for elderly patients with variceal bleed may differ.

    Article  PubMed  Google Scholar 

  29. Jakab SS, Garcia-Tsao G. Screening and Surveillance of Varices in Patients With Cirrhosis. Clin Gastroenterol Hepatol. 2019 Jan;17(1):26–29.: https://doi.org/10.1016/j.cgh.2018.03.012. Epub 2018 Mar 15. Erratum in: Clin Gastroenterol Hepatol. 2019 Apr;17(5):1009.

  30. •• de Franchis R, Bosch J, Garcia-Tsao G, Reiberger T, Ripoll C. Baveno VII Faculty Baveno VII - Renewing consensus in portal hypertension. J Hepatol. 2022;76(4):959–74. https://doi.org/10.1016/j.jhep.2021.12.022. Landmark guideline for portal hypertension.

    Article  PubMed  Google Scholar 

  31. Angulo P, Hui JM, Marchesini G, Bugianesi E, George J, Farrell GC, Enders F, Saksena S, Burt AD, Bida JP, Lindor K, Sanderson SO, Lenzi M, Adams LA, Kench J, Therneau TM, Day CP. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology. 2007;45(4):846–54. https://doi.org/10.1002/hep.21496.

    Article  CAS  PubMed  Google Scholar 

  32. Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, Montaner J, Sulkowski SM, Torriani FJ, Dieterich DT, Thomas DL, Messinger D, Nelson M. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology. 2006;43(6):1317–25. https://doi.org/10.1002/hep.21178.

    Article  CAS  PubMed  Google Scholar 

  33. Jothimani D, Danielraj S, Nallathambi B, Pandurangan B, Kalyanasundaram S, Subbiah K, Ramachandran H, Venugopal R, Dhas D, Rela M. Optimal diagnostic tool for surveillance of oesophageal varices during COVID-19 pandemic. Clin Radiol. 2021;76(7):550.e1-550.e7. https://doi.org/10.1016/j.crad.2021.02.029.

    Article  CAS  PubMed  Google Scholar 

  34. Ishiba H, Sumida Y, Tanaka S, Yoneda M, Hyogo H, Ono M, Fujii H, Eguchi Y, Suzuki Y, Yoneda M, Takahashi H, Nakahara T, Seko Y, Mori K, Kanemasa K, Shimada K, Imai S, Imajo K, Kawaguchi T, Nakajima A, Chayama K, Saibara T, Shima T, Fujimoto K, Okanoue T, Itoh Y; Japan Study Group of Non-Alcoholic Fatty Liver Disease (JSG-NAFLD). The novel cutoff points for the FIB4 index categorized by age increase the diagnostic accuracy in NAFLD: a multi-center study. J Gastroenterol. 2018 Nov;53(11):1216–1224. https://doi.org/10.1007/s00535-018-1474-y. May 9. Erratum in: J Gastroenterol. 2018.

  35. McPherson S, Hardy T, Dufour JF, Petta S, Romero-Gomez M, Allison M, Oliveira CP, Francque S, Van Gaal L, Schattenberg JM, Tiniakos D, Burt A, Bugianesi E, Ratziu V, Day CP, Anstee QM. Age as a confounding factor for the accurate non-invasive diagnosis of advanced NAFLD fibrosis. Am J Gastroenterol. 2017;112(5):740–51. https://doi.org/10.1038/ajg.2016.453.

    Article  PubMed  Google Scholar 

  36. Lebrec D, Poynard T, Hillon P, Benhamou JP. Propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a controlled study. N Engl J Med. 1981;305(23):1371–4. https://doi.org/10.1056/NEJM198112033052302.

    Article  CAS  PubMed  Google Scholar 

  37. Pascal JP, Cales P. Propranolol in the prevention of first upper gastrointestinal tract hemorrhage in patients with cirrhosis of the liver and esophageal varices. N Engl J Med. 1987 Oct 1;317(14):856-61. https://doi.org/10.1056/NEJM198710013171403. Erratum in: N Engl J Med 1988 Apr 14;318(15):994.

  38. Conn HO, Grace ND, Bosch J, Groszmann RJ, Rodés J, Wright SC, Matloff DS, Garcia-Tsao G, Fisher RL, Navasa M, et al. Propranolol in the prevention of the first hemorrhage from esophagogastric varices: A multicenter, randomized clinical trial. The Boston-New Haven-Barcelona Portal Hypertension Study Group. Hepatology. 1991;13(5):902–12.

    Article  CAS  PubMed  Google Scholar 

  39. Eugene AR, Nicholson WT. The brain and propranolol pharmacokinetics in the elderly. Brain (Bacau). 2015;6(1–4):5–14.

    PubMed  Google Scholar 

  40. Castleden CM, George CF. The effect of Aging on the hepatic clearance of propranolol. Br J Clin Pharmacol. 1979;7(1):49–54. https://doi.org/10.1111/j.1365-2125.1979.tb00896.x.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Frishman WH. Carvedilol. N Engl J Med. 1998;339(24):1759–65. https://doi.org/10.1056/NEJM199812103392407.

    Article  CAS  PubMed  Google Scholar 

  42. • Meng D, Li Z, Wang G, Ling L, Wu Y, Zhang C. Carvedilol attenuates liver fibrosis by suppressing autophagy and promoting apoptosis in hepatic stellate cells. Biomed Pharmacother. 2018;108:1617–27. https://doi.org/10.1016/j.biopha.2018.10.005. Carvedilol has a major role to play in portal hypertension.

    Article  CAS  PubMed  Google Scholar 

  43. Ding Q, Tian XG, Li Y, Wang QZ, Zhang CQ. Carvedilol may attenuate liver cirrhosis by inhibiting angiogenesis through the VEGF-Src-ERK signaling pathway. World J Gastroenterol. 2015;21(32):9566–76. https://doi.org/10.3748/wjg.v21.i32.9566.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Bakris GL, Fonseca V, Katholi RE, McGill JB, Messerli FH, Phillips RA, Raskin P, Wright JT Jr, Oakes R, Lukas MA, Anderson KM, Bell DS, GEMINI Investigators. Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial. JAMA. 2004;292(18):2227–36. https://doi.org/10.1001/jama.292.18.2227.

    Article  CAS  PubMed  Google Scholar 

  45. •• Villanueva C, Torres F, Sarin SK, Shah HA, Tripathi D, Brujats A, Rodrigues SG, Bhardwaj A, Azam Z, Hayes PC, **dal A, Abid S, Alvarado E, Bosch J, Carvedilol-IPD-MA-group and the Baveno Cooperation: an EASL Consortium. Carvedilol reduces the risk of decompensation and mortality in patients with compensated cirrhosis in a competing-risk meta-analysis. J Hepatol. 2022;77(4):1014–25. https://doi.org/10.1016/j.jhep.2022.05.021. Carvedilol is better than propranolol for portal hypertension.

    Article  CAS  PubMed  Google Scholar 

  46. Sinha R, Lockman KA, Mallawaarachchi N, Robertson M, Plevris JN, Hayes PC. Carvedilol use is associated with improved survival in patients with liver cirrhosis and ascites. J Hepatol. 2017;67(1):40–6. https://doi.org/10.1016/j.jhep.2017.02.005.

    Article  CAS  PubMed  Google Scholar 

  47. Witte KK, Clark AL. Carvedilol in the treatment of elderly patients with chronic heart failure. Clin Interv Aging. 2008;3(1):55–70. https://doi.org/10.2147/cia.s1044.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Sinagra E, Perricone G, D’Amico M, Tinè F, D’Amico G. Systematic review with meta-analysis: the haemodynamic effects of carvedilol compared with propranolol for portal hypertension in cirrhosis. Aliment Pharmacol Ther. 2014;39(6):557–68. https://doi.org/10.1111/apt.12634.

    Article  CAS  PubMed  Google Scholar 

  49. Tripathi D, Ferguson JW, Kochar N, Leithead JA, Therapondos G, McAvoy NC, Stanley AJ, Forrest EH, Hislop WS, Mills PR, Hayes PC. Randomized controlled trial of carvedilol versus variceal band ligation for the prevention of the first variceal bleed. Hepatology. 2009;50(3):825–33. https://doi.org/10.1002/hep.23045.

    Article  CAS  PubMed  Google Scholar 

  50. Shah HA, Azam Z, Rauf J, Abid S, Hamid S, Jafri W, Khalid A, Ismail FW, Parkash O, Subhan A, Munir SM. Carvedilol vs esophageal variceal band ligation in the primary prophylaxis of variceal hemorrhage: a multicentre randomized controlled trial. J Hepatol. 2014;60(4):757–64. https://doi.org/10.1016/j.jhep.2013.11.019.

    Article  CAS  PubMed  Google Scholar 

  51. • Jothimani D, Rela M, Kamath PS. Liver cirrhosis and portal hypertension: how to deal with esophageal varices? Med Clin North Am. 2023;107(3):491–504. https://doi.org/10.1016/j.mcna.2023.01.002. Understanding of portal hypertension continues to evolve.

    Article  PubMed  Google Scholar 

  52. Villanueva C, Colomo A, Bosch A, Concepción M, Hernandez-Gea V, Aracil C, Graupera I, Poca M, Alvarez-Urturi C, Gordillo J, Guarner-Argente C, Santaló M, Muñiz E, Guarner C. Transfusion strategies for acute upper gastrointestinal bleeding. N Engl J Med. 2013 Jan 3;368(1):11-21. https://doi.org/10.1056/NEJMoa1211801. Erratum in: N Engl J Med. 2013 Jun 13;368(24):2341.

  53. Zhou X, Tripathi D, Song T, Shao L, Han B, Zhu J, Han D, Liu F, Qi X. Terlipressin for the treatment of acute variceal bleeding: A systematic review and meta-analysis of randomized controlled trials. Medicine (Baltimore). 2018;97(48):e13437. https://doi.org/10.1097/MD.0000000000013437.

    Article  CAS  PubMed  Google Scholar 

  54. Qi X, Bai Z, Zhu Q, Cheng G, Chen Y, Dang X, Ding H, Han J, Han L, He Y, Ji F, ** H, Li B, Li H, Li Y, Li Z, Liu B, Liu F, Liu L, Lin S, Ma D, Meng F, Qi R, Ren T, Shao L, Tang S, Tang Y, Teng Y, Wang C, Wang R, Wu Y, Xu X, Yang L, Yuan J, Yuan S, Yang Y, Zhao Q, Zhang W, Yang Y, Guo X, **e W. Practice guidance for the use of terlipressin for liver cirrhosis-related complications. Therap Adv Gastroenterol. 2022;18(15):17562848221098252. https://doi.org/10.1177/17562848221098253.

    Article  CAS  Google Scholar 

  55. • Cavallin M, Piano S, Romano A, Fasolato S, Frigo AC, Benetti G, Gola E, Morando F, Stanco M, Rosi S, Sticca A, Cillo U, Angeli P. Terlipressin given by continuous intravenous infusion versus intravenous boluses in the treatment of hepatorenal syndrome: A randomized controlled study. Hepatology. 2016;63(3):983–92. https://doi.org/10.1002/hep.28396. Terlipressin is the key therapeutic agent in acute variceal bleed.

    Article  CAS  PubMed  Google Scholar 

  56. Seo YS, Park SY, Kim MY, Kim JH, Park JY, Yim HJ, Jang BK, Kim HS, Hahn T, Kim BI, Heo J, An H, Tak WY, Baik SK, Han KH, Hwang JS, Park SH, Cho M, Um SH. Lack of difference among terlipressin, somatostatin, and octreotide in the control of acute gastroesophageal variceal hemorrhage. Hepatology. 2014;60(3):954–63. https://doi.org/10.1002/hep.27006.

    Article  CAS  PubMed  Google Scholar 

  57. •• Garcia-Tsao G, Sanyal AJ, Grace ND, Carey WD; Practice Guidelines Committee of American Association for Study of Liver Diseases; Practice Parameters Committee of American College of Gastroenterology. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Am J Gastroenterol. 2007 Sep;102(9):2086–102. https://doi.org/10.1111/j.1572-0241.2007.01481.x. Erratum in: Am J Gastroenterol. 2007 Dec;102(12):2868. Practice guideline for variceal bleed.

  58. Acosta CJ, Goldberg D, Amin S. Evaluating the impact of frailty on periprocedural adverse events and mortality among patients with GI bleeding. Gastrointest Endosc. 2021;94(3):517-525.e11. https://doi.org/10.1016/j.gie.2021.03.021.

    Article  PubMed  Google Scholar 

  59. •• Lai JC, Sonnenday CJ, Tapper EB, Duarte-Rojo A, Dunn MA, Bernal W, Carey EJ, Dasarathy S, Kamath BM, Kappus MR, Montano-Loza AJ, Nagai S, Tandon P. Frailty in liver transplantation: an expert opinion statement from the american society of transplantation liver and intestinal community of practice. Am J Transplant. 2019;19(7):1896–906. https://doi.org/10.1111/ajt.15392. Important association between frailty and gastrointestinal bleed.

    Article  PubMed  PubMed Central  Google Scholar 

  60. • Kumar S, Asrani SK, Kamath PS. Epidemiology, diagnosis and early patient management of esophagogastric hemorrhage. Gastroenterol Clin North Am. 2014;43(4):765–82. https://doi.org/10.1016/j.gtc.2014.08.007. Increasing MELD is associated with higher mortality in acute variceal hemorrhage.

    Article  PubMed  Google Scholar 

  61. García-Pagán JC, Caca K, Bureau C, Laleman W, Appenrodt B, Luca A, Abraldes JG, Nevens F, Vinel JP, Mössner J, Bosch J, Early TIPS (Transjugular Intrahepatic Portosystemic Shunt) Cooperative Study Group. Early use of TIPS in patients with cirrhosis and variceal bleeding. N Engl J Med. 2010;362(25):2370–9. https://doi.org/10.1056/NEJMoa0910102.

    Article  PubMed  Google Scholar 

  62. Hernández-Gea V, Procopet B, Giráldez Á, Amitrano L, Villanueva C, Thabut D, Ibañez-Samaniego L, Silva-Junior G, Martinez J, Genescà J, Bureau C, Trebicka J, Llop E, Laleman W, Palazon JM, Castellote J, Rodrigues S, Gluud LL, Noronha Ferreira C, Barcelo R, Cañete N, Rodríguez M, Ferlitsch A, Mundi JL, Gronbaek H, Hernández-Guerra M, Sassatelli R, Dell’Era A, Senzolo M, Abraldes JG, Romero-Gómez M, Zipprich A, Casas M, Masnou H, Primignani M, Krag A, Nevens F, Calleja JL, Jansen C, Robic MA, Conejo I, Catalina MV, Albillos A, Rudler M, Alvarado E, Guardascione MA, Tantau M, Bosch J, Torres F, Garcia-Pagán JC, International Variceal Bleeding Observational Study Group and Baveno Cooperation. Preemptive-TIPS improves outcome in high-risk variceal bleeding: an observational study. Hepatology. 2019;69(1):282–93. https://doi.org/10.1002/hep.30182.

    Article  CAS  PubMed  Google Scholar 

  63. Saad N, Rude MK, Darcy M, Hanin JB, Wentworth A, Korenblat KM. Older age is associated with increased early mortality after transjugular intrahepatic portosystemic shunt. Ann Hepatol. 2016 Mar-Apr;15(2):215–221. https://doi.org/10.5604/16652681.1193716.

  64. •• Adlakha N, Russo MW. Outcomes after transjugular intrahepatic portosystemic shunt in cirrhotic patients 70 Years and Older. J Clin Med. 2020;9(2):381. https://doi.org/10.3390/jcm9020381. Discussion of TIPS is the elderly patient.

    Article  PubMed  PubMed Central  Google Scholar 

  65. Sharabi Y, Illan R, Kamari Y, Cohen H, Nadler M, Messerli FH, Grossman E. Diuretic induced hyponatraemia in elderly hypertensive women. J Hum Hypertens. 2002;16(9):631–5. https://doi.org/10.1038/sj.jhh.1001458.

    Article  CAS  PubMed  Google Scholar 

  66. Heidemann J, Bartels C, Berssenbrügge C, Schmidt H, Meister T. Hepatorenal syndrome: outcome of response to therapy and predictors of survival. Gastroenterol Res Pract. 2015;2015:457613. https://doi.org/10.1155/2015/457613.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Funding

None.

Author information

Authors and Affiliations

  1. Institute of Liver disease and Transplantation, Dr Rela Institute and Medical Centre, Chennai, India

    Dinesh Jothimani & Mohamed Rela

  2. Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine and Science, Rochester, MN, 55906, USA

    Patrick S. Kamath

Authors
  1. Dinesh Jothimani
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mohamed Rela
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Patrick S. Kamath
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Dinesh Jothimani.

Ethics declarations

Conflict of Interest

None.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jothimani, D., Rela, M. & Kamath, P.S. Management of Portal Hypertension in the Older Patient. Curr Gastroenterol Rep (2024). https://doi.org/10.1007/s11894-024-00930-y

Download citation

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s11894-024-00930-y

Keywords

Search

Navigation